

CLOCCs result from a stereotyped pathophysiologic cascade involving inflammatory cytokine release (IL-1, IL-6, TNF-α), blood-brain barrier breakdown, astrocyte activation, and massive extracellular glutamate accumulation leading to cytotoxic edema.
The splenium's vulnerability reflects the high concentration of oligodendrocytes with abundant glutamate receptors, explaining the stereotyped preference for this location despite diverse underlying etiologies.
Unlike other corpus callosum lesions, CLOCCs do not produce hemispheric disconnection syndromes such as alien hand syndrome, apraxia, or visual field defects.
Seizure-related CLOCCs (from seizures themselves or antiseizure medication cessation) typically present as small, well-circumscribed lesions, whereas metabolic or infectious etiologies tend to produce larger, more irregular boomerang-shaped lesions.
Complete radiographic resolution within 1 week to 1 month post-recovery favors CLOCCs, distinguishing them from chronic demyelination or infarction.
Prognosis is favorable in seizure-related and antiseizure medication-related cases but depends on underlying etiology in metabolic, infectious, or toxic contexts.
Describe CLOCCs as transient cytotoxic lesions with restricted diffusion in the splenium (and potentially extending into the body or hemispheres in boomerang pattern), emphasizing the lack of enhancement and the specific ADC reduction to support the cytotoxic rather than vasogenic edema pattern, while commenting on the expected complete resolution within weeks in the appropriate clinical context.